- €2.99bn
- €3.54bn
- €2.63bn
- 95
- 58
- 33
- 69
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,933 | 2,576 | 2,556 | 2,557 | 2,627 |
Cost of Revenue | |||||
Gross Profit | 916 | 884 | 876 | 912 | 976 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,663 | 2,313 | 2,306 | 2,427 | 2,381 |
Operating Profit | 270 | 263 | 250 | 129 | 246 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 224 | 218 | 218 | 114 | 220 |
Provision for Income Taxes | |||||
Net Income After Taxes | 172 | 191 | 191 | 81.8 | 156 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 191 | 566 | 198 | 79.3 | 155 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 191 | 566 | 198 | 79.3 | 155 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.63 | 1.77 | 2.03 | 0.801 | 1.4 |
Dividends per Share |